ADAP Advocacy Releases Final Report on Patient Perspectives of Long-Acting Injectables
ADAP Advocacy releases final report on patient perspectives of Long-Acting Injectables (LAIs) for HIV treatment and prevention
This news matters because it sheds light on the challenges faced by people living with HIV and HIV-negative individuals in accessing important medications. The report provides valuable insights that can help address the attitudinal, operational, and other barriers preventing patients from accessing life-changing products for the treatment and prevention of HIV.
